Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EDR
1701
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $880K | ﹤0.01% |
36,782
+20,569
| +127% | +$458K |
|
1702
Patrick Industries
PATK
$2.79B
| $879K | ﹤0.01% |
19,173
+5,331
| +39% | +$247K |
|
1703
Nu Skin
NUS
$236M
| $879K | ﹤0.01% |
22,384
+12,069
| +117% | +$502K |
|
1704
Vir Biotechnology
VIR
$1.52B
| $878K | ﹤0.01% |
37,716
+24,522
| +186% | +$627K |
|
1705
TripAdvisor
TRIP
$1.26B
| $878K | ﹤0.01% |
44,177
+24,332
| +123% | +$520K |
|
1706
Minerals Technologies
MTX
$2.25B
| $877K | ﹤0.01% |
14,532
+7,764
| +115% | +$483K |
|
1707
Axsome Therapeutics
AXSM
$11.2B
| $877K | ﹤0.01% |
14,224
+9,256
| +186% | +$608K |
|
|
ODP
1708
DELISTED
ODP
ODP
| $875K | ﹤0.01% |
19,463
+10,458
| +116% | +$510K |
|
1709
Pegasystems
PEGA
$5.15B
| $871K | ﹤0.01% |
35,948
+19,510
| +119% | +$411K |
|
1710
Northern Oil and Gas
NOG
$2.57B
| $869K | ﹤0.01% |
28,652
+16,048
| +127% | +$500K |
|
1711
SIGA Technologies
SIGA
$206M
| $868K | ﹤0.01% |
151,045
+57,270
| +61% | +$383K |
|
1712
American Financial Group
AFG
$12B
| $867K | ﹤0.01% |
7,141
+5
| +0.1% | +$659 |
|
|
HTO
1713
H2O America
HTO
$2.62B
| $862K | ﹤0.01% |
11,320
+5,811
| +105% | +$449K |
|
1714
Dana Inc
DAN
$3.2B
| $861K | ﹤0.01% |
57,240
+30,957
| +118% | +$507K |
|
|
B
1715
DELISTED
Barnes Group Inc.
B
| $858K | ﹤0.01% |
21,318
+11,540
| +118% | +$486K |
|
1716
Towne Bank
TOWN
$3.49B
| $858K | ﹤0.01% |
32,205
+22,407
| +229% | +$662K |
|
1717
Supernus Pharmaceuticals
SUPN
$2.78B
| $854K | ﹤0.01% |
23,589
+12,894
| +121% | +$496K |
|
|
HBI
1718
DELISTED
Hanesbrands
HBI
| $852K | ﹤0.01% |
162,118
+98,853
| +156% | +$622K |
|
1719
Agilysys
AGYS
$3.03B
| $844K | ﹤0.01% |
10,240
+5,697
| +125% | +$461K |
|
1720
WesBanco
WSBC
$4.07B
| $841K | ﹤0.01% |
27,392
+16,935
| +162% | +$599K |
|
1721
Xerox
XRX
$412M
| $840K | ﹤0.01% |
54,563
+28,193
| +107% | +$456K |
|
1722
Warrior Met Coal
HCC
$5.11B
| $840K | ﹤0.01% |
22,890
+12,460
| +119% | +$461K |
|
1723
Liberty Global Class C
LBTYK
$3.46B
| $838K | ﹤0.01% |
41,106
| – | – |
|
1724
CareTrust REIT
CTRE
$9.25B
| $837K | ﹤0.01% |
42,749
+23,270
| +119% | +$455K |
|
|
PRLH
1725
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
| $835K | ﹤0.01% |
80,000
| – | – |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.